214 related articles for article (PubMed ID: 24888765)
1. The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons.
Faje AT; Klibanski A
Endocrine; 2015 Feb; 48(1):79-82. PubMed ID: 24888765
[No Abstract] [Full Text] [Related]
2. Treatment of hyperprolactinemia in post-menopausal women: pros.
Iacovazzo D; De Marinis L
Endocrine; 2015 Feb; 48(1):76-8. PubMed ID: 25112228
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemic disorders.
Katz E; Adashi EY
Clin Obstet Gynecol; 1990 Sep; 33(3):622-39. PubMed ID: 2225590
[No Abstract] [Full Text] [Related]
4. [Hyperprolactinemia unrelated to prolactinoma].
Krysiak R; Okopień B
Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
[TBL] [Abstract][Full Text] [Related]
5. Prolactinomas.
Glezer A; Bronstein MD
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
[TBL] [Abstract][Full Text] [Related]
6. [Hyperprolactinemia in the postmenopause: versions and contraversions].
Leshchenko OY
Ter Arkh; 2021 Oct; 93(10):1234-1239. PubMed ID: 36286827
[TBL] [Abstract][Full Text] [Related]
7. Hyperprolactinemia after menopause: Diagnosis and management.
Auriemma RS; Pirchio R; Pivonello R; Colao A
Maturitas; 2021 Sep; 151():36-40. PubMed ID: 34446277
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinemia and prolactinoma.
Romijn JA
Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
[TBL] [Abstract][Full Text] [Related]
9. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
[TBL] [Abstract][Full Text] [Related]
10. [Hyperprolactinemia and prolactinomas].
Croughs RJ; van 't Verlaat JW
Ned Tijdschr Geneeskd; 1991 Nov; 135(47):2210-3. PubMed ID: 1956454
[No Abstract] [Full Text] [Related]
11. Patient guide to hyperprolactinemia diagnosis and treatment.
Hoffman AR; Melmed S; Schlechte J
J Clin Endocrinol Metab; 2011 Feb; 96(2):35A-6A. PubMed ID: 21296988
[No Abstract] [Full Text] [Related]
12. Hyperprolactinemia and lens opacities.
Costagliola C; Mastropasqua L; Amato G; Carella C
Ann Ophthalmol; 1992 Nov; 24(11):418-9. PubMed ID: 1476397
[TBL] [Abstract][Full Text] [Related]
13. [Hyperprolactinemia].
Müller OA; von Werder K
Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
[No Abstract] [Full Text] [Related]
14. Treatment of hyperprolactinemia in major depression.
Holroyd S; Cohen MJ
Am J Psychiatry; 1990 Jun; 147(6):810. PubMed ID: 2094233
[No Abstract] [Full Text] [Related]
15. [Prolactin-secreting microadenoma in menopausal women].
Barka I; Dendana E; Chikhrouhou N; Maroufi A; Kacem M; Chadli M; Ach K
Pan Afr Med J; 2017; 27():177. PubMed ID: 28904704
[TBL] [Abstract][Full Text] [Related]
16. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.
Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P
J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134
[TBL] [Abstract][Full Text] [Related]
17. [Prolactinoma].
Glezer A; Bronstein MD
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):118-23. PubMed ID: 24830588
[TBL] [Abstract][Full Text] [Related]
18. Speed of response to dopaminergic agents in prolactinomas.
Hage C; Salvatori R
Endocrine; 2022 Mar; 75(3):883-888. PubMed ID: 34846682
[TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia/Prolactinomas in the Postmenopausal Period: Challenges in Diagnosis and Management.
Pekić S; Medic Stojanoska M; Popovic V
Neuroendocrinology; 2019; 109(1):28-33. PubMed ID: 30347396
[TBL] [Abstract][Full Text] [Related]
20. Indications for surgery in the treatment of hyperprolactinemia.
Zacur HA
J Reprod Med; 1999 Dec; 44(12 Suppl):1127-31. PubMed ID: 10649823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
